Effect of subclinical esketamine on NLRP3 and cognitive dysfunction in elderly ischemic stroke patients
Subclinical doses of esketamine might reduce postoperative cognitive dysfunction risk and offer neuroprotection, presenting potential therapeutic options for elderly ischemic stroke patients.
Authors
- Lang Wang (ORCID: https://orcid.org/0000-0003-2004-7669)
- Jianping Zhang (ORCID: https://orcid.org/0000-0003-2012-7837)
- Baoxin Ma
Institutions
- Zhongshan Hospital of Xiamen University (CN)
Publication Details
- Journal
- Open Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1515/med-2025-1193
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00